Last updated: August 2, 2023
Sponsor: Cabinet Medical
Overall Status: Active - Recruiting
Phase
N/A
Condition
Diabetes Prevention
Diabetes And Hypertension
Hypertriglyceridemia
Treatment
VLCKD
Clinical Study ID
NCT05984459
FMH Endocrinol and Diabetol
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Have a diagnosis of type 2 diabetes
- Being overweight (BMI > 25 kg/m^2) or obesity (BMI > 29.9 kg/m^2)
- Have wished to engage in a weight loss program according to the PnK® method
- Have accepted and signed the consent for the use of data
Exclusion
Exclusion Criteria:
- Pregnancy or lactation
- Type 1 diabetes
- Eating disorders
- Psychiatric disorders
- Have any contraindication for doing the active or ketogenic phase
Study Design
Total Participants: 39
Treatment Group(s): 1
Primary Treatment: VLCKD
Phase:
Study Start date:
January 30, 2023
Estimated Completion Date:
August 30, 2023
Study Description
Connect with a study center
Dr. Daniela Sofra
Lausanne, 1003
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.